Today: 21 May 2026
D-Wave Quantum stock today: QBTS edges lower after hours with CES 2026 in focus
31 December 2025
2 mins read

D-Wave Quantum stock today: QBTS edges lower after hours with CES 2026 in focus

NEW YORK, December 31, 2025, 17:21 ET — After-hours

  • D-Wave Quantum shares down 0.4% at $26.15 in after-hours trading
  • Stock traded in a $26.05–$27.42 range on the last trading day of 2025
  • Traders are watching January conference appearances for fresh business updates

D-Wave Quantum Inc (QBTS) shares were down 0.4% at $26.15 in after-hours trading on Wednesday, capping a choppy final session of 2025. The stock traded between $26.05 and $27.42, with about 36 million shares changing hands.

The quantum-computing stock is up about 211% year-to-date, but still sits roughly 44% below its 52-week high of $46.75. Short interest stands near 12% of the public float, a setup that can amplify moves when liquidity thins.

Why it matters now is timing. U.S. stock markets are closed on Thursday for New Year’s Day, leaving traders to reassess positions when markets reopen on Friday.

The holiday break also shifts attention to early-January events, when companies in emerging themes often try to frame the next leg of the story. For D-Wave, that means investor focus is tilting from year-end tape action to what management and customers say in public forums.

Moves in other U.S.-listed quantum pure plays were modest in late trading. IonQ fell about 0.9%, Rigetti Computing slid roughly 1.1%, and Quantum Computing Inc was down about 1.3%.

D-Wave’s next visible catalyst is a January appearance tied to CES 2026. The company said it will sponsor the CES Foundry at Fontainebleau Las Vegas on Jan. 7-8, and will showcase its annealing quantum computing technology and “hybrid” quantum-classical solvers — software that pairs quantum hardware with traditional computers to tackle specific problems. “Showcasing quantum computing at CES, one of the world’s most influential technology stages, signals that the technology is quickly moving into the mainstream,” said Murray Thom, D-Wave’s vice president of quantum technology evangelism, in the statement. D-Wave Quantum

Annealing quantum computing is designed to search for good solutions to complex optimization problems — the kinds of routing and scheduling tasks that can bog down classical systems. It is distinct from “gate-model” quantum computing, the approach used for more general-purpose quantum algorithms.

Investors will be looking for evidence that demos and customer case studies translate into measurable commercial traction. In practice, that often means updates on customer deployments, recurring cloud usage and the pace of new bookings, rather than breakthroughs in raw hardware performance.

D-Wave has also pointed to its annual Qubits user conference in Boca Raton, Florida, on Jan. 27-28 as another venue where executives, customers and industry speakers will discuss applications and roadmaps. That event is on the calendar for traders who expect conference-driven volatility in thin early-year markets.

For now, the stock’s late-December behavior shows how quickly sentiment can flip in the sector. With a strong 2025 run already in the books, investors are weighing whether January catalysts can keep attention on the group — or whether profit-taking dominates the first weeks of 2026.

When trading resumes after the New Year holiday, the next test for QBTS will be whether it can hold recent levels into CES week — and whether any incremental updates change expectations for revenue conversion and cash burn in 2026.

Stock Market Today

  • Sensex nudges up as oil prices drop and rupee strengthens
    May 21, 2026, 3:46 AM EDT. Indian shares edged higher on Thursday, with the BSE Sensex up 0.20% and the Nifty 50 gaining 0.30%. The rise followed a decline in Brent crude oil prices, which dipped 5.6% near $106 a barrel, and a rebound in the rupee supported by Reserve Bank of India dollar sales. Despite early gains fading, investor sentiment improved amid easing inflation pressures and stabilizing currency. Key earnings influenced moves, with Apollo Hospitals posting a 36% profit increase and Lenskart Solutions reporting 46% revenue growth. Caution persisted over Ola Electric due to a 5% revenue decline. Market momentum depends on crude oil trends and rupee stability as investors balance earnings strength against macroeconomic challenges like high U.S. bond yields.

Latest articles

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

21 May 2026
Federal Reserve minutes released Wednesday showed most officials see possible rate hikes if inflation remains above 2%. Markets and economists have pushed back expectations for rate cuts, with some now anticipating increases. The Fed’s benchmark rate held at 3.50% to 3.75% in April. The next FOMC meeting is set for June 16-17.
Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop